INVENTIVA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-28
Kyle Yen
Analyst
UBS
Equibles does not estimate personal net worth.
About Kyle Yen
Kyle Yen is recorded as Analyst at UBS. Kyle Yen has spoken on 1 earnings call across 1 company, most recently for INVENTIVA on September 28, 2026. The companies whose calls Kyle Yen spoke on are classified in the Healthcare sector.
Kyle Yen on recent calls
“So we did notice that Native 3 enrolled a meaningfully higher proportion of F3 patients relative to Native 2. So how do you expect that to impact both efficacy on the drug arms and placebo arm?”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
Inventiva H1 2026 financial report
INVENTIVA